Literature DB >> 29525845

Anti-neutrophil cytoplasmic antibodies and their clinical significance.

Supaporn Suwanchote1, Muanpetch Rachayon1, Pongsawat Rodsaward1, Jongkonnee Wongpiyabovorn1, Tawatchai Deekajorndech2, Helen L Wright3, Steven W Edwards4, Michael W Beresford5,6, Pawinee Rerknimitr7,8, Direkrit Chiewchengchol9,10,11.   

Abstract

Anti-neutrophil cytoplasmic antibodies (ANCA) are a group of autoantibodies that cause systemic vascular inflammation by binding to target antigens of neutrophils. These autoantibodies can be found in serum from patients with systemic small-vessel vasculitis and they are considered as a biomarker for ANCA-associated vasculitis (AAV). A conventional screening test to detect ANCA in the serum is indirect immunofluorescence study, and subsequently confirmed by enzyme-linked immunosorbent assay. A positive staining of ANCA can be classified into three main categories based on the staining patterns: cytoplasmic, perinuclear, and atypical. Patients with granulomatosis with polyangiitis (GPA) mostly have a positive cytoplasmic staining pattern (c-ANCA) whilst a perinuclear pattern (p-ANCA) is more common in microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA) patients. Atypical pattern (a-ANCA) is rarely seen in patients with systemic small-vessel vasculitis but it can be found in other conditions. Here, techniques for ANCA detection, ANCA staining patterns and their clinical significances are reviewed.

Entities:  

Keywords:  ANCA; ANCA staining pattern; ANCA-associated vasculitis

Mesh:

Substances:

Year:  2018        PMID: 29525845     DOI: 10.1007/s10067-018-4062-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  98 in total

Review 1.  Antineutrophil cytoplasmic antibodies.

Authors:  Xavier Bosch; Antonio Guilabert; Josep Font
Journal:  Lancet       Date:  2006-07-29       Impact factor: 79.321

Review 2.  Immune regulatory mechanisms in ANCA-associated vasculitides.

Authors:  Nikola Lepse; Wayel H Abdulahad; Cees G M Kallenberg; Peter Heeringa
Journal:  Autoimmun Rev       Date:  2011-08-11       Impact factor: 9.754

Review 3.  ASCA, ANCA, ALCA and Many More: Are They Useful in the Diagnosis of Inflammatory Bowel Disease?

Authors:  Guangxi Zhou; Yang Song; Wenjing Yang; Yanmin Guo; Leilei Fang; Yamei Chen; Zhanju Liu
Journal:  Dig Dis       Date:  2016-03-16       Impact factor: 2.404

4.  Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.

Authors:  Bertha M Córdova-Sánchez; Juan M Mejía-Vilet; Luis E Morales-Buenrostro; Georgina Loyola-Rodríguez; Norma O Uribe-Uribe; Ricardo Correa-Rotter
Journal:  Clin Rheumatol       Date:  2016-02-06       Impact factor: 2.980

5.  Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.

Authors:  Johannes R Hov; Kirsten M Boberg; Eli Taraldsrud; Mette Vesterhus; Maria Boyadzhieva; Inger Camilla Solberg; Erik Schrumpf; Morten H Vatn; Benedicte A Lie; Øyvind Molberg; Tom H Karlsen
Journal:  Liver Int       Date:  2016-09-13       Impact factor: 5.828

6.  Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?

Authors:  Julia U Holle; Wolfgang L Gross; Konstanze Holl-Ulrich; Petra Ambrosch; Bernhard Noelle; Marcus Both; Elena Csernok; Frank Moosig; Susanne Schinke; Eva Reinhold-Keller
Journal:  Ann Rheum Dis       Date:  2010-05-28       Impact factor: 19.103

Review 7.  ANCA-Associated Vasculitis: Pathogenesis, Models, and Preclinical Testing.

Authors:  Holly L Hutton; Stephen R Holdsworth; A Richard Kitching
Journal:  Semin Nephrol       Date:  2017-09       Impact factor: 5.299

Review 8.  ANCA-associated vasculitis with renal involvement.

Authors:  Valentina Binda; Gabriella Moroni; Piergiorgio Messa
Journal:  J Nephrol       Date:  2017-05-30       Impact factor: 3.902

9.  Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis.

Authors:  Alfred Mahr; Frédéric Batteux; Sarah Tubiana; Claire Goulvestre; Michel Wolff; Thomas Papo; François Vrtovsnik; Isabelle Klein; Bernard Iung; Xavier Duval
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

10.  Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness.

Authors:  T Y Avery; J Bons; P van Paassen; J Damoiseaux
Journal:  Lupus       Date:  2016-07       Impact factor: 2.911

View more
  19 in total

1.  Clinical relevance of ANCA in small-vessel vasculitis: positioning of antigen-specific immunoassays.

Authors:  Jan Damoiseaux; Xavier Bossuyt
Journal:  Clin Rheumatol       Date:  2018-05-25       Impact factor: 2.980

Review 2.  Update on vasculitis: an overview and dermatological clues for clinical and histopathological diagnosis - part I.

Authors:  Thâmara Cristiane Alves Batista Morita; Gabriela Franco S Trés; Roberta Fachini Jardim Criado; Mirian Nacagami Sotto; Paulo Ricardo Criado
Journal:  An Bras Dermatol       Date:  2020-03-26       Impact factor: 1.896

3.  Antineutrophil cytoplasmic antibodies and their relationship with disease activity and presence of staphylococcal superantigens in nasal swabs in patients having granulomatosis with polyangiitis: results of a study involving 115 patients from a single center.

Authors:  Justyna Fijolek; E Wiatr; V Petroniec; E Augustynowicz-Kopec; M Bednarek; D Gawryluk; K Roszkowski-Sliz
Journal:  Clin Rheumatol       Date:  2019-07-23       Impact factor: 2.980

Review 4.  The promise of precision medicine in rheumatology.

Authors:  Joel M Guthridge; Catriona A Wagner; Judith A James
Journal:  Nat Med       Date:  2022-07-04       Impact factor: 87.241

Review 5.  Serum ANCA as Disease Biomarkers: Clinical Implications Beyond Vasculitis.

Authors:  Marco Folci; Giacomo Ramponi; Virginia Solitano; Enrico Brunetta
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-30       Impact factor: 10.817

Review 6.  Thrombosis and Anticoagulation Therapy in Systemic Lupus Erythematosus.

Authors:  Wenjun Yuan; Fengjun Guan
Journal:  Autoimmune Dis       Date:  2022-06-27

7.  [Value of anti-neutrophil cytoplasmic antibody in assessing the severity of bronchiolitis obliterans in children].

Authors:  Xiao-Wen Chen; De-Hui Chen; Shang-Zhi Wu; Na Xie; Wen-Kuan Liu; Yu-Neng Lin; Ya-Wen Zhang; Qing-Si Zeng
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-09

8.  SARS-CoV-2 infection as a trigger of autoimmune response.

Authors:  Maria C Sacchi; Stefania Tamiazzo; Paolo Stobbione; Lisa Agatea; Piera De Gaspari; Anna Stecca; Ernesto C Lauritano; Annalisa Roveta; Renato Tozzoli; Roberto Guaschino; Ramona Bonometti
Journal:  Clin Transl Sci       Date:  2021-01-21       Impact factor: 4.689

Review 9.  ANCA-Associated Vasculitides and Hematologic Malignancies: Lessons from the Past and Future Perspectives.

Authors:  Marco Folci; Giacomo Ramponi; Dana Shiffer; Aurora Zumbo; Michele Agosti; Enrico Brunetta
Journal:  J Immunol Res       Date:  2019-05-06       Impact factor: 4.818

10.  Granulomatous arteritis limited to the skin: case report and etiologic differential diagnosis.

Authors:  Diego Henrique Morais Silva; Neusa Yuriko Sakai Valente; Agatha Ramos Oppenheimer; Anna Karoline Gouveia de Oliveira
Journal:  An Bras Dermatol       Date:  2022-03-21       Impact factor: 2.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.